Comparison of self-reported and public registered absenteeism among people on long-term sick leave due to musculoskeletal disorders: criterion validity of the iMTA Productivity Cost Questionnaire

Rikke Munk Killingmo, Anne Therese Tveter, Milada C Småstuen, Kjersti Storheim, Margreth Grotle, Rikke Munk Killingmo, Anne Therese Tveter, Milada C Småstuen, Kjersti Storheim, Margreth Grotle

Abstract

Objective: To evaluate criterion validity of the iMTA Productivity Cost Questionnaire (iPCQ) by comparing iPCQ-reported occurrence and duration of long-term absenteeism (> 4 weeks) with public registry data collected from the Norwegian Labour and Welfare Administration (NAV) among people on sick leave due to musculoskeletal disorders.

Method: Baseline data from a cohort study was used, in which people on sick leave for at least 4 weeks due to musculoskeletal disorders were recruited electronically through the NAV website. To compare the occurrence of long-term absenteeism overall agreement between the two methods was measured by percentages. To compare the duration (number of days with absenteeism) and adjusted duration (number of days with complete absenteeism) of long-term absenteeism we conducted intraclass correlation coefficient (ICC) two-way random average agreement, descriptive statistic and Wilcoxon signed-rank test.

Results: In total, 144 participants with a median age (range) of 49 (24-67) were included. The overall agreement on the occurrence of long-term absenteeism was 100%. The ICC value was 0.97 and 0.86 for duration and adjusted duration of long-term absenteeism, respectively. The median difference(iPCQ-registry) between the two methods was 0 and 17 days for long-term absenteeism duration and adjusted duration, respectively. A significant difference between the two methods was observed (Wilcoxon signed-rank test, p < 0.001) with regards to adjusted duration of long-term absenteeism.

Conclusion: The iPCQ showed good agreement with public registry data regarding the occurrence and duration of long-term absenteeism among people with musculoskeletal disorders on long-term sick-leave in Norway. However, the iPCQ does not cover part-time sick-leave and thereby potentially overestimate the total amount of long-term absenteeism.

Trial registration: ClinicalTrials.gov Identifier no. NCT04196634.

Keywords: Absenteeism; Measurement properties; Musculoskeletal disorders; Productivity costs.

Conflict of interest statement

The authors declare that they have no conflict of interest.

© 2021. The Author(s).

Figures

Fig. 1
Fig. 1
The difference between iPCQ and registry-recorded long-term absenteeism duration plotted against the registry-recorded data. The central horizontal line represents the mean difference, the flanking lines represent the 95% limits of agreement
Fig. 2
Fig. 2
The difference between iPCQ and registry-recorded long-term absenteeism adjusted duration plotted against the registry-recorded data. The central horizontal line represents the mean difference, the flanking lines represent the 95% limits of agreement

References

    1. Burdorf A. Economic evaluation in occupational health—its goals, challenges, and opportunities. Scand. J. Work Environ. Health. 2007;33(3):161–164. doi: 10.5271/sjweh.1127.
    1. Krol M, Brouwer W, Rutten F. Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics. 2013;31(7):537–549. doi: 10.1007/s40273-013-0056-3.
    1. Johns G, Miraglia M. The reliability, validity, and accuracy of self-reported absenteeism from work: a meta-analysis. J. Occup. Health Psychol. 2015;20(1):1–14. doi: 10.1037/a0037754.
    1. Bouwmans C, et al. The iMTA Productivity Cost Questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health. 2015;18(6):753–758. doi: 10.1016/j.jval.2015.05.009.
    1. Tang K. Estimating productivity costs in health economic evaluations: a review of instruments and psychometric evidence. Pharmacoeconomics. 2015;33(1):31–48. doi: 10.1007/s40273-014-0209-z.
    1. Zhang W, Bansback N, Anis AH. Measuring and valuing productivity loss due to poor health: a critical review. Soc. Sci. Med. 2011;72(2):185–192. doi: 10.1016/j.socscimed.2010.10.026.
    1. Beemster TT, et al. Test–retest reliability, agreement and responsiveness of productivity loss (iPCQ-VR) and healthcare utilization (TiCP-VR) questionnaires for sick workers with chronic musculoskeletal pain. J. Occup. Rehabil. 2019;29:91–103. doi: 10.1007/s10926-018-9767-9.
    1. Munk R, et al. Measuring productivity costs in patients with musculoskeletal disorders: measurement properties of the Institute for Medical Technology Assessment Productivity Cost Questionnaire. Value Health. 2019;22(12):1410–1416. doi: 10.1016/j.jval.2019.07.011.
    1. Zhang W, Anis AH. Health-related productivity loss: NICE to recognize soon, good to discuss now. Pharmacoeconomics. 2014;32(5):425–427. doi: 10.1007/s40273-014-0149-7.
    1. Global Burden of Disease Study, C Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386(9995):743–800. doi: 10.1016/S0140-6736(15)60692-4.
    1. Bevan S. Economic impact of musculoskeletal disorders (MSDs) on work in Europe. Best Pract. Res. Clin. Rheumatol. 2015;29(3):356–373. doi: 10.1016/j.berh.2015.08.002.
    1. Tveter AT, et al. Risk assessment for prolonged sickness absence due to musculoskeletal disorders: protocol for a prospective cohort study. BMC Musculoskelet. Disord. 2020;21(1):326. doi: 10.1186/s12891-020-03354-7.
    1. Von Korff M, Jensen MP, Karoly P. Assessing global pain severity by self-report in clinical and health services research. Spine (Phila Pa 1976) 2000;25(24):3140–3151. doi: 10.1097/00007632-200012150-00009.
    1. Bouwmans, C., et al.: Manual: iMTA Productivity Costs Questionnaire. 2013, Institute for Medical Technology Assessment.
    1. Kanters, T.: Questionnaires for the measurement of costs in economic evaluations. 2019 [cited 2019 09.10.2019]
    1. Terwee CB, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J. Clin. Epidemiol. 2007;60(1):34–42. doi: 10.1016/j.jclinepi.2006.03.012.
    1. Mokkink, L.B., et al.: COSMIN study design checklist for patient-reported outcome measurement instruments. 2019:
    1. Andresen EM. Criteria for assessing the tools of disability outcomes research. Arch. Phys. Med. Rehabil. 2000;81(12 Suppl 2):S15–20. doi: 10.1053/apmr.2000.20619.
    1. Grovle L, et al. Poor agreement found between self-report and a public registry on duration of sickness absence. J. Clin. Epidemiol. 2012;65(2):212–218. doi: 10.1016/j.jclinepi.2011.05.009.
    1. Voss M, et al. Comparisons of self-reported and register data on sickness absence among public employees in Sweden. Occup. Environ. Med. 2008;65(1):61–67. doi: 10.1136/oem.2006.031427.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren